Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis

Jehn Hsiahn Yang, Mei Jou Chen, Ming Yih Wu, Yi Chun Chen, Yu Shih Yang, Hong Nerng Ho

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Objective: To examine changes in local cytokine production in the eutopic endometrium of adenomyosis after treatment with medroxyprogesterone acetate (MPA) and danazol. Design: Prospective cohort study. Setting: Tertiary university hospital. Patient(s): Twenty-four women with adenomyosis (study group) and 22 women without adenomyosis (control group). Intervention(s): Eutopic endometrium was separated into single endometrial stromal cells (ESCs), and was cultured in vitro alone, with MPA (10-7 M), or with danazol (10-7 M) for 8 days. Main Outcome Measure(s): Messenger RNA expression of interleukin (IL)-6, IL-8, and tumor necrosis factor-α in ESCs, and their concentrations in the supernatants of ESCs. Result(s): A significant decrease of IL-6 concentration in the supernatant, measured by ELISA, was found with time of ESCs cultured with MPA and danazol in the control group, but not in adenomyosis. The IL-6 mRNA in ESCs determined by real-time quantitative polymerase chain, as well as its concentration in the supernatant, was much higher in adenomyosis than that in the control group after treatment with MPA and danazol for 8 days. Conclusion(s): Medroxyprogesterone acetate and danazol appeared to have a decreased effect on the suppression of IL-6 liberated by ESCs in adenomyosis. This aberrant secretion of IL-6 might play a role in the formation of ectopic endometrial implants in adenomyosis.

Original languageEnglish
Pages (from-to)1459-1465
Number of pages7
JournalFertility and Sterility
Volume86
Issue number5
DOIs
Publication statusPublished - Nov 1 2006
Externally publishedYes

Fingerprint

Female Contraceptive Agents
Uterine Diseases
Adenomyosis
Estrogen Antagonists
Danazol
Medroxyprogesterone Acetate
Drug Combinations
Endometriosis
Stromal Cells
Endometrium
Cultured Cells
Interleukin-6
Cohort Studies
Gene Expression
Control Groups
Therapeutics
Messenger RNA
Interleukin-8
Tertiary Care Centers
Tumor Necrosis Factor-alpha

Keywords

  • Adenomyosis
  • danazol
  • endometrial stromal cell
  • interleukin-6
  • medroxyprogesterone acetate

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Cite this

Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis. / Yang, Jehn Hsiahn; Chen, Mei Jou; Wu, Ming Yih; Chen, Yi Chun; Yang, Yu Shih; Ho, Hong Nerng.

In: Fertility and Sterility, Vol. 86, No. 5, 01.11.2006, p. 1459-1465.

Research output: Contribution to journalArticle

@article{58fdcf21f51f46b8a2be57f10c1d2af1,
title = "Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis",
abstract = "Objective: To examine changes in local cytokine production in the eutopic endometrium of adenomyosis after treatment with medroxyprogesterone acetate (MPA) and danazol. Design: Prospective cohort study. Setting: Tertiary university hospital. Patient(s): Twenty-four women with adenomyosis (study group) and 22 women without adenomyosis (control group). Intervention(s): Eutopic endometrium was separated into single endometrial stromal cells (ESCs), and was cultured in vitro alone, with MPA (10-7 M), or with danazol (10-7 M) for 8 days. Main Outcome Measure(s): Messenger RNA expression of interleukin (IL)-6, IL-8, and tumor necrosis factor-α in ESCs, and their concentrations in the supernatants of ESCs. Result(s): A significant decrease of IL-6 concentration in the supernatant, measured by ELISA, was found with time of ESCs cultured with MPA and danazol in the control group, but not in adenomyosis. The IL-6 mRNA in ESCs determined by real-time quantitative polymerase chain, as well as its concentration in the supernatant, was much higher in adenomyosis than that in the control group after treatment with MPA and danazol for 8 days. Conclusion(s): Medroxyprogesterone acetate and danazol appeared to have a decreased effect on the suppression of IL-6 liberated by ESCs in adenomyosis. This aberrant secretion of IL-6 might play a role in the formation of ectopic endometrial implants in adenomyosis.",
keywords = "Adenomyosis, danazol, endometrial stromal cell, interleukin-6, medroxyprogesterone acetate",
author = "Yang, {Jehn Hsiahn} and Chen, {Mei Jou} and Wu, {Ming Yih} and Chen, {Yi Chun} and Yang, {Yu Shih} and Ho, {Hong Nerng}",
year = "2006",
month = "11",
day = "1",
doi = "10.1016/j.fertnstert.2006.04.034",
language = "English",
volume = "86",
pages = "1459--1465",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis

AU - Yang, Jehn Hsiahn

AU - Chen, Mei Jou

AU - Wu, Ming Yih

AU - Chen, Yi Chun

AU - Yang, Yu Shih

AU - Ho, Hong Nerng

PY - 2006/11/1

Y1 - 2006/11/1

N2 - Objective: To examine changes in local cytokine production in the eutopic endometrium of adenomyosis after treatment with medroxyprogesterone acetate (MPA) and danazol. Design: Prospective cohort study. Setting: Tertiary university hospital. Patient(s): Twenty-four women with adenomyosis (study group) and 22 women without adenomyosis (control group). Intervention(s): Eutopic endometrium was separated into single endometrial stromal cells (ESCs), and was cultured in vitro alone, with MPA (10-7 M), or with danazol (10-7 M) for 8 days. Main Outcome Measure(s): Messenger RNA expression of interleukin (IL)-6, IL-8, and tumor necrosis factor-α in ESCs, and their concentrations in the supernatants of ESCs. Result(s): A significant decrease of IL-6 concentration in the supernatant, measured by ELISA, was found with time of ESCs cultured with MPA and danazol in the control group, but not in adenomyosis. The IL-6 mRNA in ESCs determined by real-time quantitative polymerase chain, as well as its concentration in the supernatant, was much higher in adenomyosis than that in the control group after treatment with MPA and danazol for 8 days. Conclusion(s): Medroxyprogesterone acetate and danazol appeared to have a decreased effect on the suppression of IL-6 liberated by ESCs in adenomyosis. This aberrant secretion of IL-6 might play a role in the formation of ectopic endometrial implants in adenomyosis.

AB - Objective: To examine changes in local cytokine production in the eutopic endometrium of adenomyosis after treatment with medroxyprogesterone acetate (MPA) and danazol. Design: Prospective cohort study. Setting: Tertiary university hospital. Patient(s): Twenty-four women with adenomyosis (study group) and 22 women without adenomyosis (control group). Intervention(s): Eutopic endometrium was separated into single endometrial stromal cells (ESCs), and was cultured in vitro alone, with MPA (10-7 M), or with danazol (10-7 M) for 8 days. Main Outcome Measure(s): Messenger RNA expression of interleukin (IL)-6, IL-8, and tumor necrosis factor-α in ESCs, and their concentrations in the supernatants of ESCs. Result(s): A significant decrease of IL-6 concentration in the supernatant, measured by ELISA, was found with time of ESCs cultured with MPA and danazol in the control group, but not in adenomyosis. The IL-6 mRNA in ESCs determined by real-time quantitative polymerase chain, as well as its concentration in the supernatant, was much higher in adenomyosis than that in the control group after treatment with MPA and danazol for 8 days. Conclusion(s): Medroxyprogesterone acetate and danazol appeared to have a decreased effect on the suppression of IL-6 liberated by ESCs in adenomyosis. This aberrant secretion of IL-6 might play a role in the formation of ectopic endometrial implants in adenomyosis.

KW - Adenomyosis

KW - danazol

KW - endometrial stromal cell

KW - interleukin-6

KW - medroxyprogesterone acetate

UR - http://www.scopus.com/inward/record.url?scp=33750193673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750193673&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2006.04.034

DO - 10.1016/j.fertnstert.2006.04.034

M3 - Article

VL - 86

SP - 1459

EP - 1465

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 5

ER -